57 Results for "

CBR

" in MedChemExpress (MCE) Product Catalog:
Products (57)

57 Results for "CBR" in MCE Product Catalog:

34
34 Publications Verification
Cat. No.: HY-N0148
CAS No.: 153-18-4
Synonyms: Rutoside; Quercetin 3-O-rutinoside
Rutin (Rutoside) is a flavonoid found in many plants and shows a wide range of biological activities including anti-inflammatory, antidiabetic, antioxidant, neuroprotective, nephroprotective, hepatoprotective and reducing Aβ oligomer activities. Rutin is also a CBR1 inhibitor, which can cross the blood brain barrier. Rutin attenuates vancomycin-induced renal tubular cell apoptosis via suppression of apoptosis, mitochondrial dysfunction, and oxidative stress .
loading...
    loading...
21
21 Cited Publications
Cat. No.: HY-100012
CAS No.: 681159-27-3
Purity:  98.73%
Research Areas:  

Cancer

CBR-5884 is an active, selective inhibitor of phosphoglycerate dehydrogenase (PHGDH) with an IC50 of 33 μM. CBR-5884 inhibits de novo serine synthesis in cancer cells and is selectively toxic to cancer cell lines with high serine biosynthetic activity. CBR-5884 selectively inhibits the proliferation of melanoma and breast cancer lines that have a high propensity for serine synthesis .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-13930
CAS No.: 22688-79-5
Purity:  99.96%
Synonyms: Quercetin 3-O-glucuronide; Quercetin 3-glucuronide
Miquelianin (Quercetin 3-O-glucuronide) is a metabolite of quercetin and a type of natural flavonoid. Miquelianin is also a CBR1 inhibitor. Miquelianin is permeable to the blood-brain barrier .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-N2609
CAS No.: 2196-14-7
7,4'-Dihydroxyflavone (7,4'-DHF) is a flavonoid, which can be isolated from Glycyrrhiza uralensis. 7,4'-Dihydroxyflavone is eotaxin/CCL11 inhibitor and CBR1 inhibitor (IC50=0.28 μM). 7,4'-Dihydroxyflavone has the ability to consistently suppress eotaxin production and prevent dexamethasone (Dex)‐paradoxical adverse effects on eotaxin production . 7,4'-Dihydroxyflavone (7,4'-DHF) inhibits MUC5AC gene expression, mucus production and secretion via regulation of NF-κB, STAT6 and HDAC2.7,4'-Dihydroxyflavone (7,4'-DHF) decreases phorbol 12-myristate 13-acetate (PMA) stimulated NCI-H292 human airway epithelial cell MUC5AC gene expression and mucus production with IC50 value of 1.4 µM .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-134205A
CAS No.: 2416095-06-0
Purity:  98.02%
Target:  

Keap1-Nrf2

CBR-470-1 is an inhibitor of the glycolytic enzyme phosphoglycerate kinase 1 (PGK1). CBR-470-1 is also a non-covalent Nrf2 activator. CBR-470-1 protects SH-SY5Y neuronal cells against MPP +-induced cytotoxicity through activation of the Keap1-Nrf2 cascade .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N0148R
CAS No.: 153-18-4
Synonyms: Rutoside (Standard); Quercetin 3-O-rutinoside (Standard)
Rutin (Standard) is the analytical standard of Rutin. This product is intended for research and analytical applications. Rutin (Rutoside) is a flavonoid found in many plants and shows a wide range of biological activities including anti-inflammatory, antidiabetic, antioxidant, neuroprotective, nephroprotective, hepatoprotective and reducing Aβ oligomer activities. Rutin is also a CBR1 inhibitor, which can cross the blood brain barrier. Rutin attenuates vancomycin-induced renal tubular cell apoptosis via suppression of apoptosis, mitochondrial dysfunction, and oxidative stress .
loading...
    loading...
Cat. No.: HY-W008137
CAS No.: 62802-38-4
5-Bromo-2-fluoropyrimidine is a polyhalogenated pyrimidine and chemoselective amination substrate.5-Bromo-2-fluoropyrimidine undergoes chemoselective amination at the C-2 position (C-F bond) with no amination at the C-5 position (C-Br bond) in the presence of a Cu(II)/PTABS catalytic system .
loading...
    loading...
Cat. No.: HY-156694
CAS No.: 833481-77-9
Purity:  99.92%
Hydroxy-PP-Me is a selective CBR1 inhibitor with an IC50 of 759 nM. Hydroxy-PP-Me can inhibit serum starvation-induced apoptosis. Hydroxy-PP-Me can enhance the cytotoxic effects of Daunorubicin (HY-13062A) and As2O3 on tumor cells. Hydroxy-PP-Me can be used in the research of cancer such as leukemia .
loading...
    loading...
Cat. No.: HY-134001
CAS No.: 2416095-00-4
Purity:  99.45%
Target:  

Keap1-Nrf2

Research Areas:  

Metabolic Disease

CBR-470-2, a glycine-substituted analog, can activate NRF2 signaling. CBR-470-2 can be used for the research of modulation glycolysis .
loading...
    loading...
Cat. No.: HY-157445
CAS No.: 891101-69-2
Target:  

NADPH Oxidase

Research Areas:  

Metabolic Disease

CBR1-IN-3 (compound 13h) is a potent inhibitor of carbonyl reductase 1 (CBR1), with IC50 value of 0.034 μM .
loading...
    loading...
Cat. No.: HY-155587
CAS No.: 833481-60-0
Purity:  99.66%
Target:  

Carbonyl Reductase Src

Research Areas:  

Cancer

Hydroxy-PP is a potent carbonyl reductase 1 (CBR1) inhibitor with an IC50 value of 0.78 μM. Hydroxy-PP also potently inhibits the cytoplasmic tyrosine kinase Fyn with an IC50 value of 5 nM .
loading...
    loading...
Cat. No.: HY-135184
CAS No.: 922717-97-3
Synonyms: CBR-2092; TNP-2092
Research Areas:  

Infection

Rifaquizinone (CBR-2092) is a Rifamycin-Quinolone Hybrid Antibiotic. Rifaquizinone inhibits wild-type S. aureus RNA polymerase with an IC50 of 34 nM. Rifaquizinone is effective against S. aureus infections, with MICs ranged from 0.008 to 0.5 μg/mL for 300 clinical isolates of staphylococci and streptococci .
loading...
    loading...
Cat. No.: HY-121710
CAS No.: 23869-24-1
Purity:  97.02%
Synonyms: 7-Monohydroxyethylrutoside
Target:  

Carbonyl Reductase

Research Areas:  

Cardiovascular Disease

MonoHER (7-Monohydroxyethylrutoside) is a Carbonyl reductase 1 (CBR1) inhibitor and can be used as a cardioprotective agent. MonoHER inhibits the activity of CBR1 V88 and CBR1 I88 in a concentration-dependent manner .
loading...
    loading...
Cat. No.: HY-117485
CAS No.: 1776931-05-5
Target:  

Hedgehog

Research Areas:  

Inflammation/Immunology

CBR-096-4 is a derivative of Itraconazole (HY-17514). CBR-096-4 is an orally active antifibrotic agent with no CYP3A4 inhibitory activity. CBR-096-4 inhibits the formation of matrix-secreting activated myofibroblasts (MFBs) from multiple tissue types. CBR-096-4 inhibits Hedgehog reporter activity (GLI-LUC), VEGF-dependent growth, and αSMA-LUC reporter activity. CBR-096-4 can be used for research of fibrosis .
loading...
    loading...
Cat. No.: HY-151107
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

CBR Agonist-2 is a CB1 agonist (CB1R; CB1 ligand) with an EC50 and a Ki of 960 nM and 970 nM, respectively. CBR Agonist-2 is a promising tool for investigating the involvement of hCB1R in disorders associated with the endocannabinoid system .
loading...
    loading...
Cat. No.: HY-151105
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

CBR Agonist-1 (27a-cis) is a cannabinoid receptor (CBR) agonist with the Ki values of 0.18 μM for CB1R and 1.22 μM for CB2R. CBR Agonist-1 (27a-cis) can be used in the study of endogenous cannabinoid system-related diseases .
loading...
    loading...
Cat. No.: HY-RS18341
Research Areas:  

Others

Cbr1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cbr1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-W744549
CAS No.: 116-58-5
Synonyms: 20β-DHF
20β-Dihydrocortisol (20β-DHF) is a metabolite of Hydrocortisone (Cortisol) (HY-N0583). 20β-Dihydrocortisol is a weak endogenous agonist of the glucocorticoid receptor (GR). 20β-Dihydrocortisol can be converted from Hydrocortisone via CBR1 catalysis, a process dependent on NADPH. 20β-Dihydrocortisol can be used for the study of obesity .
loading...
    loading...
Cat. No.: HY-157451
CAS No.: 1119826-35-5
Target:  

Carbonyl Reductase

Research Areas:  

Cancer

CBR1-IN-7 (Compound JV-2) is a human CBR1 inhibitor (IC50=8 μM). CBR1-IN-7 can be used in cancer research .
loading...
    loading...
Cat. No.: HY-157447
CAS No.: 1798284-64-6
Target:  

Carbonyl Reductase

Research Areas:  

Cancer

CBR1-IN-4 (Compound 13p) is a human carbonyl reductase 1 (CBR1) inhibitor (IC50=0.09 μM). CBR1-IN-4 can be used in cancer research .
loading...
    loading...